Simbio S high‼️ Frontrio continuing decline! GNI steady! Asian development!
Caelum Bioscience announced that after the end of trading that day, it has submitted to the Pharmaceuticals and Medical Devices Agency (PMDA) a clinical trial plan notification for the cancer treatment antibody "CBA-1535" currently under development.
× ![]()